Bcl-3 overexpression is also associated with a number of cancers that do not harbor BCL3-associated translocations, including classical Hodgkin’s and peripheral T-cell lymphoma [22], chronic lymphocytic leukemia [23], adult T cell leukemia [24], and certain solid tumors [25,26]. This evidence concerns the gene BCL3 and cancer.